regenold GmbH
Christine von der Brelie has extensive experience in human resources, currently serving as Head of Human Resources at regenold GmbH since April 2017. Prior to this role, Christine held positions at KIM Training Consulting Coaching from January 2014 to January 2019, where responsibilities included office management and financial controlling. At Losan Pharma GmbH from July 2007 to April 2017, Christine led the human resources department, overseeing personnel management and recruitment, as well as collaboration with the works council. Earlier experience includes a role in sales and recruitment at Randstad Deutschland from July 2006 to June 2007. Christine holds a Diplom Betriebswirtin degree in Business Administration from Hochschule für angewandte Wissenschaften Kempten, earned between 2001 and 2006.
This person is not in any teams
regenold GmbH
regenold GmbH is specialized in pharmaceutical development, regulatory and market access. Founded in 1994, we have helped many clients progress their product developments by providing scientific and regulatory advice, through to gaining regulatory approval and marketing authorization both nationally and internationally. Our ultimate aim is to help clients maximize the value of their product or device’s life cycle amid a constantly evolving regulatory and market access environment. By developing innovative, tailored, and cost-effective strategies, we help clients achieve milestones in regulatory approval and market access. In 2001 we founded regulanet® which is a network of independent regulatory consultancies and experts with representation in over 90 countries throughout the world. The network members offer services to a wide variety of national and international pharmaceutical and healthcare clients, including all aspects of development, regulatory and market access in their respective countries. For more information please visit: https://www.regulanet.com In order to service the increasing interest and importance of medical devices, regenold GmbH has a division CE plus, which specializes in international regulatory affairs for medical devices and in vitro diagnostics including combination products, companion diagnostics and medical apps. The core competence of CEplus is CE marking for the European market as well as offering associated activities to assist clients realize market success. CE plus is linked with regulanet® and therefore able to access resources and manage complex international projects on behalf of clients. For more information please visit: http://www.ceplus.eu